Navigation Links
Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the World's First 'Smart' Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use
Date:5/30/2008

c

Lutronic is one of the world's leading developers and manufacturers of medical laser systems serving the clinical dermatological and aesthetic communities. With over a decade of award-winning technology design that includes its Spectra line of products and its unparalleled MOSAIC Systems, the company is committed to delivering innovative, highly effective, and painless laser solutions. In addition, Lutronic, Inc. offers an impressive service department featuring experienced laser engineers who provide the highest level of service and support to physicians across the US. Manufacturing medical laser systems for markets in Europe and Asia, parent Lutronic Co. Ltd. is based in Seoul, South Korea and delivers products to over 40 countries. To learn more about the MOSAIC eCO2 Laser System, please visit http://www.lutronic.com.

Contact:

Ken Reich

Director, Marketing & Public Relations

Lutronic, Inc.

Phone: 609 275-1565 x302 or 888 588-7644

Fax: 609 275-3800

Email: kreich@lutronic.com

This release was issued through eReleases (TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Lutronic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Medicare and Medicaid Data Released: Featuring Up-To-Date Enrollment Trends, State Initiatives, Regional Market Share and Prescription Drug Benefits
2. Lutronic Inc. Announces FDA Clearance of Its Spectra VRM III Q-Switched Nd: Yag Laser System for Treating a Broad Spectrum of Dermatological and Aesthetic Conditions
3. Elbit Imaging Ltd. Announces First Quarter Results for 2008
4. ASTRO announces 2008 gold medalists
5. Alma Lasers Announces FDA Clearance of the Harmony(XL) Multi-Application System at THE Aesthetic Show 2008
6. Darwin Announces Creation of New Health Care and Errors and Omissions Divisions
7. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
8. Ekahau Announces Compatibility With 802.11n
9. Orphan Therapeutics Announces Initiation of Rolling NDA Submission for LUCASSIN(R) (terlipressin) for the Treatment of Hepatorenal Syndrome Type 1
10. DRAXIS Announces Completion of Sale to Jubilant
11. WellPoint Announces Realignment of Operations, Technology and Government Services Unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...breathing passage, which results due to smoking is...y 2020. // Called Chronic Obstructive Pulmonary ...ealth problems: chronic-obstructive bronchitis and...nlike simple bronchitis, the breathing passages na...
...water stored in plastic containers for a very long...lease a deadly toxin named as antimony to the wate...er the water is stored, reported the online editio...ert William Shotyk tested ground water and 15 type...
...e is an appropriate climate where new ideas can th...climate. // There are a variety of social problems...ills and resources. Collaboration is an essential ...on is only useful when there is application for th...
...as in public glare for the wrong reasons, having u...d and for not being party to a movement that promo...ds Agency got after Tesco, soon after the latter r...alth warnings on products at traffic lights. Tesco...
Other Medicine News:Health News:Health Care System in US Needs a Change 2
(Date:8/18/2008)...ewswire-USNewswire/ -- Boston University and Aubre...r for Human Genetics, Inc.,("CHG") and Director of...y,announced that CHG will no longer offer testing...agnostics, Inc., These patented tests include tes...1555G or Connexin 26 mutations, developmental diso...
(Date:8/18/2008)...al Trials Phase of Test Development Program, ORAN...-- Beckman,Coulter, Inc. (NYSE: BEC ) announced t...S. royalty obligation to Nephromics LLC, a Chestnu...lth. The license is for tests,related to the detec...ia, a,leading cause of maternal death. In addition...
(Date:8/18/2008)...18 /- Micromet, Inc.,(Nasda... novel, proprietary,antibodies for the treatment o...ll host a webcast and conference call this morning...ime (4:00 p.m. Central European,Time) to discuss t...urnal,SCIENCE on August 15, 2008., To access the ...
(Date:8/14/2008)...- AstraZeneca (NYSE: AZN )...h the National Cancer,Centre Singapore (NCCS) and ...anti-cancer compounds. The collaboration, which is...that was signed today, aims to further,build Astra... ultimately,speed up access to new medicines of po...
Breaking Medicine Technology:Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 2Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 5AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 6Experimental technique at GUMC offers real time analysis of breast cancer biopsies 6246 1Experimental technique at GUMC offers real time analysis of breast cancer biopsies 6246 2Experimental technique at GUMC offers real time analysis of breast cancer biopsies 6246 3National Network to End Domestic Violence Fund Introduces New Tool to Outsmart Abusers and Stalkers in Todays High Tech World 6242 1National Network to End Domestic Violence Fund Introduces New Tool to Outsmart Abusers and Stalkers in Todays High Tech World 6242 2Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 6237 1Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 6237 2Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 6237 3First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 1First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 2First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 3First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 4
...zation with a Bavituximab Equivalent and Irradiate...From 0% in Controls in a,Preclinical Model of Brai...18, 2007,/PRNewswire-FirstCall/ -- Peregrine Pharm...cal company developing targeted,monoclonal antibod...rus (HCV) infection, today announced preclinical s...
..., Wash., April 18, 2007 /PRNewswire-FirstCall/ -- ...Falla, Ph.D, Chief,Scientific Officer, will presen...ll molecule peptide (lipohexapeptide) technology,a... will take place,at the Boston Convention & Ex... 9th. Dr. Falla,s presentation is scheduled for,We...
Other Medicine Technology:Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 2Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 3Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 4Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 5Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 6Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 2Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 3Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 4
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: